Affiliation:
1. KNR University of Health Sciences, Warangal, Telangana, India
Abstract
: Comparative study of Dydrogesterone versus oral sustained release micronized hydroxy-progesterone for support of luteal phase.: A randomized controlled trial, performed from March 2022 to April 2023. 200 women between 18–40 years of age attending infertility OPD at Gandhi hospital were enrolled in this study. Subjects were randomized and were given either oral dydrogesterone or oral sustained release micronized hydroxy-progesterone. Statistical analysis was done accordingly.In the present study, oral dydrogesterone was demonstrated to be superior than sustained release micronized hydroxy-progesterone, with UPT positive rates being 83% and 30% respectively. Dydrogesterone given orally was tolerated well with similar safety profile to sustained release micronized hydroxy-progesterone.Our study results depicted the use of dydrogesterone to be effective when compared to oral sustained release micronized hydroxy-progesterone in terms of luteal phase support. Dydrogesterone is hailed to be superior in regards of positive pregnancy rates in the current study.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference19 articles.
1. Taylor HS, Pal L, Sell E, Definitions of infertility and recurrent pregnancy loss.Speroff's Clinical Gynecologic Endocrinology and Infertility.
2. Wang X, Chen C, Wang L, Chen D, Guang W, French J, Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study.Fertil Steril 2003;79(3):577-84
3. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin.Fertil Steril 2008;89(4):789-92
4. Luteal phase support for assisted reproduction cycles
5. Shapiro D, Boostanfar R, Silverberg K, Yanushpolsky EH, Examining the evidence:progesterone supplementation during fresh and frozen embryo transfer.Reprod Biomed Online 2014;29(Suppl 1):1-14